"The University of Miami Health System combines patient care, research, and education to create a front-line approach to health care."

During the past decade, Bascom Palmer Eye Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bascom Palmer Eye Institute" are "Geographic Atrophy" (3 trials) and "Diabetic Macular Edema" (1 trials). Many other conditions were trialed in "Bascom Palmer Eye Institute" in a lesser frequency.

Most popular intervention types in "Bascom Palmer Eye Institute" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials), "Faricimab" (1 trials), "No intervention" (1 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bascom Palmer Eye Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Bascom Palmer Eye Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Bascom Palmer Eye Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Bascom Palmer Eye Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".